Preoperative Serum Carbohydrate Antigen 19-9 Levels Cannot Predict the Surgical Resectability of Pancreatic Cancer: A Meta-Analysis [PDF]
Background and Aims: Pancreatic ductal adenocarcinoma has one of the worst prognosis of all malignancies. This investigated the relationship between the preoperative serum carbohydrate antigen 19-9 and surgical resectability.Methods: A systematic search ...
Márton Benke +19 more
doaj +3 more sources
Carbohydrate antigen 19-9-producing splenic cyst: a case report [PDF]
We describe the case of a 40s woman with a carbohydrate antigen (CA)19-9-producing splenic cyst. The lesion was detected incidentally at the splenic hilum, and resected after 5 years of follow-up.
Norihiro Shinkawa, MD, PhD +4 more
doaj +5 more sources
Prognostic Value of Carbohydrate Antigen 19‐9 and the Surgical Margin in Extrahepatic Cholangiocarcinoma [PDF]
Aim The prognostic value of the perioperative carbohydrate antigen 19‐9 (CA19‐9) value and the prognostic relationship between the CA19‐9 value and the surgical margin in extrahepatic cholangiocarcinoma (EHCC) have not been fully discussed.
Ryusei Yamamoto +6 more
doaj +3 more sources
Tumor-Associated Carbohydrate Antigen 19-9 (CA 19-9), a Promising Target for Antibody-Based Detection, Diagnosis, and Immunotherapy of Cancer. [PDF]
Carbohydrate antigen 19–9 (CA 19–9) also known as sialyl Lewis A is a tetrasaccharide overexpressed on a wide range of cancerous cells. CA 19–9 has been detected at elevated levels in sera of patients with various types of malignancies, most prominently ...
Nakisa A +6 more
europepmc +4 more sources
Holistic Understanding of the Role of Carbohydrate Antigen 19-9 in Pancreatic Cancer Screening, Early Diagnosis, and Prognosis: A Systematic Review. [PDF]
Pancreatic ductal adenocarcinoma (PDAC) is a significant challenge due to its silent progression and well-advanced, unresectable, complicated presentation.
Janga LSN +6 more
europepmc +2 more sources
Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer. [PDF]
BACKGROUND Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of death from cancer worldwide. Tumor markers like carbohydrate antigen 19-9 (CA 19-9) have been proven valuable as a diagnostic tool and a predictor for tumor staging and response to ...
Balaban DV +11 more
europepmc +2 more sources
Diagnostic and economic value of carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 72-4 in gastrointestinal cancers. [PDF]
BACKGROUND The diagnostic and economic value of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9) and CA72-4 for gastrointestinal malignant tumors lacked evaluation in a larger scale.
Liu HN +9 more
europepmc +2 more sources
Increased carbohydrate antigen 19‐9 expression in a thymic neuroendocrine tumor [PDF]
Here, we report a case of carbohydrate antigen (CA) 19‐9‐producing mediastinal neuroendocrine tumor (NET) (atypical carcinoid). A 54‐year‐old woman with no specific relevant medical history was referred to our hospital because of increased CA19‐9 (95.3 U/
Yuki Shimizu +5 more
doaj +2 more sources
Alpha-fetoprotein and carbohydrate antigen 19-9 as prognostic biomarkers in acute liver failure: A retrospective study [PDF]
Objective To investigate the clinical significance of alpha-fetoprotein and carbohydrate antigen 19-9 as potential predictors of outcomes in patients with acute liver failure. Methods We conducted a retrospective analysis of 208 patients with acute liver
Rui Qi +6 more
doaj +2 more sources
Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer. [PDF]
PURPOSE Circulating carbohydrate antigen 19-9 (CA19-9) levels reflect FUT3 and FUT2 fucosyltransferase activity. Measuring the related glycan, DUPAN-2, can be useful in individuals unable to synthesize CA19-9.
Ando Y +15 more
europepmc +2 more sources

